Nuclear Energy Agency (NEA) – Current Trends in the Supply and Utilisation of Medical Radioisotopes
Medical radioisotopes support millions of diagnostic and therapeutic procedures annually. As such, they serve as essential components of modern health care. This report provides extensive coverage of both traditional radioisotope supply challenges for molybdenum-99 and the developing field of radioligand therapy (RLT) and theranostics.
Drawing on more than 15 years of experience to analyse production capacity, innovation pipelines, regulatory frameworks and health care system readiness, this report offers strategic policy recommendations to guarantee long-term sustainable access to established and new radioisotopes for all stakeholders. It will be particularly useful to government officials, health care professionals and industry leaders working to establish resilient supply chains and patient-centred nuclear medicine innovation. It provides a forward-looking view of how policy and investment choices today can shape the future landscape of nuclear medicine.
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
vNvyVs1QnpwAV9uv
